Literature DB >> 36177190

Pituitary corticotroph identity and receptor-mediated signaling: a transcriptomics perspective.

Stanko S Stojilkovic1, Rafael M Previde1, Arthur S Sherman2, Patrick A Fletcher2.   

Abstract

Recent single-cell RNA sequencing has offered an unprecedented view of pituitary cell transcriptomic profiles. In this review, these new data are briefly discussed and compared with the classical literature, focusing on pituitary corticotrophs. These cells are introduced by discussing their marker genes, followed by a review of G protein-coupled receptor gene expression, heterotrimeric G protein genes, and genes encoding signaling pathways downstream of G proteins: adenylate cyclases, phosphodiesterases, phospholipases, and protein kinases. The expression patterns of enzyme-linked plasma membrane and nuclear hormone receptor genes was also analyzed. The overview of these selected groups of genes sheds new light on corticotrophic receptors and their signaling pathways and provides guidance for further basic and clinical research by identifying genes that not been studied so far.

Entities:  

Keywords:  G protein-coupled receptors; corticotrophs; enzyme-linked receptors; nuclear hormone receptors; pituitary; scRNAseq; signaling pathways

Year:  2022        PMID: 36177190      PMCID: PMC9514143          DOI: 10.1016/j.coemr.2022.100364

Source DB:  PubMed          Journal:  Curr Opin Endocr Metab Res        ISSN: 2451-9650


  79 in total

Review 1.  Structure, function, and control of phosphoinositide-specific phospholipase C.

Authors:  M J Rebecchi; S N Pentyala
Journal:  Physiol Rev       Date:  2000-10       Impact factor: 37.312

Review 2.  Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use.

Authors:  Andrew T Bender; Joseph A Beavo
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 3.  Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells.

Authors:  Mara Boschetti; Federico Gatto; Marica Arvigo; Daniela Esposito; Alberto Rebora; Miryam Talco; Manuela Albertelli; Elena Nazzari; Umberto Goglia; Francesco Minuto; Diego Ferone
Journal:  Neuroendocrinology       Date:  2010-09-10       Impact factor: 4.914

4.  Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.

Authors:  Y Aoki; Y Iwasaki; M Katahira; Y Oiso; H Saito
Journal:  Endocrinology       Date:  1997-05       Impact factor: 4.736

Review 5.  Phospholipase D.

Authors:  Mark McDermott; Michael J O Wakelam; Andrew J Morris
Journal:  Biochem Cell Biol       Date:  2004-02       Impact factor: 3.626

6.  cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors.

Authors:  Graeme B Bolger; Mariana F Bizzi; Sergio V Pinheiro; Giampaolo Trivellin; Lisa Smoot; Mary-Ann Accavitti; Márta Korbonits; Antonio Ribeiro-Oliveira
Journal:  Endocr Relat Cancer       Date:  2016-05       Impact factor: 5.678

7.  Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas.

Authors:  K E Friend; Y K Chiou; M B Lopes; E R Laws; K M Hughes; M A Shupnik
Journal:  J Clin Endocrinol Metab       Date:  1994-06       Impact factor: 5.958

8.  Calcineurin feedback inhibition of agonist-evoked cAMP formation.

Authors:  F A Antoni; R J Barnard; M J Shipston; S M Smith; J Simpson; J M Paterson
Journal:  J Biol Chem       Date:  1995-11-24       Impact factor: 5.157

Review 9.  Nuclear Receptors as Regulators of Pituitary Corticotroph Pro-Opiomelanocortin Transcription.

Authors:  Dongyun Zhang; Anthony P Heaney
Journal:  Cells       Date:  2020-04-07       Impact factor: 6.600

10.  Cell Type- and Sex-Dependent Transcriptome Profiles of Rat Anterior Pituitary Cells.

Authors:  Patrick A Fletcher; Kosara Smiljanic; Rafael Maso Prévide; James R Iben; Tianwei Li; Milos B Rokic; Arthur Sherman; Steven L Coon; Stanko S Stojilkovic
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.